MT:EURONEXT AMSTERDAMArcelorMittal SA Analysis
Data as of 2026-03-10 - not real-time
$56.77
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
ArcelorMittal is trading just above its 50‑day moving average while remaining below the 20‑day average, indicating a modest short‑term pullback within a longer‑term uptrend. The RSI sits in the mid‑40s, suggesting neutral momentum, and the MACD histogram is negative, flagging bearish divergence. A beta above 1.3 and 30‑day volatility exceeding 50% highlight heightened price swings, yet the stock benefits from increasing volume and a clear bullish trend direction. The current price is modestly above the DCF‑derived fair value, but still offers roughly an 8% upside to analyst target levels, supporting a fair valuation stance. Fundamentals show a low price‑to‑book ratio under 1, a forward PE under 9x, and a dividend yield above 1% with a very low payout ratio, underscoring value characteristics and dividend sustainability. Operating cash flow remains positive, though free cash flow is negative, reflecting ongoing capital investment. Recent earnings highlighted strong EBITDA growth and a strategic push into renewable energy capacity, adding a growth narrative to the otherwise value‑oriented profile. Sector exposure to steel cycles and environmental regulation adds layers of risk, while the company’s global footprint spreads geographic risk across multiple regions. Overall, the blend of modest valuation upside, solid dividend coverage, and strategic growth initiatives positions the stock for cautious accumulation.
Investors should monitor the support level near the low‑50s and the resistance near the high‑60s, as a breakout above resistance could accelerate upside. The bearish MACD and neutral RSI suggest waiting for confirmation before adding on a short‑term basis, but the longer‑term fundamentals and strategic initiatives justify a buy stance for medium to long horizons.
Investors should monitor the support level near the low‑50s and the resistance near the high‑60s, as a breakout above resistance could accelerate upside. The bearish MACD and neutral RSI suggest waiting for confirmation before adding on a short‑term basis, but the longer‑term fundamentals and strategic initiatives justify a buy stance for medium to long horizons.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near technical support
- bearish MACD divergence
- neutral RSI indicating limited upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- fair valuation with ~8% upside to analyst targets
- strong EBITDA growth and renewable‑energy expansion
- sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- global steel demand recovery potential
- strategic diversification into clean energy
- robust balance sheet despite high debt levels
Key Metrics & Analysis
Financial Health
Revenue Growth1.70%
Profit Margin5.14%
P/E Ratio13.8
ROE6.01%
ROA1.11%
Debt/Equity23.72
P/B Ratio0.8
Op. Cash Flow$4.8B
Free Cash Flow$-2181750016
Technical Analysis
TrendBullish
RSI43.0
Support$52.10
Resistance$67.60
MA 20$62.66
MA 50$55.88
MA 200$40.97
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Fair Value$55.22
Target Price$61.40
Upside/Downside8.16%
GradeFair
TypeValue
Dividend Yield1.07%
Risk Assessment
Beta1.36
Volatility55.42%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.